Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    OK!

    The Dolphins Challenge Cancer event April 10, 2021 (virtual or in-person)

    February 27th, 2021 Support Me Howdy! The Dolphins Challenge Cancer event will take place on April 10, 2021. The DCC is a collective community movement to raise money in support of much needed Sarcoma cancer research. Consider...

    Read Article

    Virtual Dialogue 2: Innovations in Diagnosing and Treating Chondrosarcoma: March 20, 1:00PM EST

    February 14th, 2021The registration is now open for the Chondrosarcoma Foundation's Second International Virtual Dialogue. It is scheduled for Saturday, March 20, 2021 from 1:00pm - 2:30pm (EST/ New York time) on Zoom. Please register at...

    Read Article

    Registration for Cancer Cell Virtual Symposium February 8-11

    February 7th, 2021Webinar Series Global Cell Therapy Virtual Symposium The journey from discovery to therapy begins with a single cell The path from research to effective cancer immune cell therapies requires innovative approaches to match the challenges we face....

    Read Article

    Chondrosarcoma Awareness Day is One Week Away.

    January 30th, 2021One week from today is Chondrosarcoma Awareness Day. Thank you for going on our web site and signing on to support our petition for Chondrosarcoma Research and Clinical Trials. The Chondrosarcoma Foundation is initiating an international public...

    Read Article

    A medication to treat Soft Tissue Sarcomas gets FDA approval

    January 30th, 2021Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment of Soft Tissue Sarcoma (STS) Immunicum AB (publ; IMMU.ST) announced today that it has received Orphan Drug Designation (ODD) from the U.S. Food and Drug...

    Read Article

    A clinical trial for treating Metastatic Convention Chondrosarcoma

    January 30th, 2021Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in...

    Read Article

    Chondrosarcoma Awareness Day is in 11 days

    January 27th, 2021We are 11 days from Chondrosarcoma Awareness Day. If you have not already done this, we are counting on you to do the following: 1. Get the Word Out. Join us in our efforts to educate the public about Chondrosarcoma, a rare bone and soft tissue...

    Read Article

    Getting Media Attention: Chondrosarcoma CS Foundation, Inc. Initiates Worldwide Campaign to Proclaim February 6, 2021 As Chondrosarcoma Awareness Day

    January 24th, 2021The Chondrosarcoma Awareness Day is getting the attention from many media outlets across the globe. We are doing our best to raise awareness and support for Chondrosarcoma research and clinical trials. Please check out the links...

    Read Article
    Skip to content